Interstitial Lung Disease Trial, Not Yet Recruiting (NCT07315425)

Interstitial Lung Disease Trial, Not Yet Recruiting NCT07315425 Sponsor: Gazi University Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07315425 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a lung condition called interstitial lung disease, based on recognised medical guidelines.
You are willing to take part in the study and sign a consent form agreeing to participate.

Who may not be able to join:

You currently have any kind of active infection.
You have a bone, joint, or nerve condition that affects your ability to exercise.
You have a health condition that means exercise testing would not be safe for you, based on established sports medicine guidelines (confirm with trial site).
You have had COVID-19 in the last three months.
You are receiving any treatments other than standard, routine medical care for your condition.
You have a condition that affects blood flow in the arteries of your legs or arms (peripheral arterial disease).
You have a condition that causes damage or loss of feeling in the nerves of your hands or feet (peripheral neuropathy).
Your resting blood pressure is higher than 160/100 mmHg.
You have a history of a blood clot in a vein (deep vein thrombosis), a blood clot in the lungs (pulmonary embolism), or a stroke.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Meral Boşnak Güçlü, Prof. Dr., Gazi University

Phone: 03122162647

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07315425

Sponsor: Gazi University

Phase: Not Applicable

Status: Not Yet Recruiting

Condition: Interstitial Lung Disease

Trial contact: 03122162647

More information: https://clinicaltrials.gov/study/NCT07315425

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a lung condition called interstitial lung disease, based on recognised medical guidelines.
You are willing to take part in the study and sign a consent form agreeing to participate.

Who may not be able to join:

You currently have any kind of active infection.
You have a bone, joint, or nerve condition that affects your ability to exercise.
You have a health condition that means exercise testing would not be safe for you, based on established sports medicine guidelines (confirm with trial site).
You have had COVID-19 in the last three months.
You are receiving any treatments other than standard, routine medical care for your condition.
You have a condition that affects blood flow in the arteries of your legs or arms (peripheral arterial disease).
You have a condition that causes damage or loss of feeling in the nerves of your hands or feet (peripheral neuropathy).
Your resting blood pressure is higher than 160/100 mmHg.
You have a history of a blood clot in a vein (deep vein thrombosis), a blood clot in the lungs (pulmonary embolism), or a stroke.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Not Applicable

Sponsor

Gazi University

Registry

ClinicalTrials.gov

Start date

1 February 2026

Est. completion

1 December 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Hemodynamic Responses; Hemodynamic Responses (Heart Rate); Hemodynamic Responses (Systolic Blood Pressure); Hemodynamic Responses (Diastolic Blood Pressure); Hemodynamic Responses (Peripheral Oxygen Saturation (SpO₂)); Hemodynamic Responses (Respiratory Rate); Hemodynamic Responses (Dyspnea); Hemodynamic Responses (Fatigue (Whole-body and Leg)); Hemodynamic Responses (Maximum Heart Rate)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov